BioSpace News Archive

Pharm Country

PTC Therapeutics Announces Evrysdi® Royalty Agreement with Royalty Pharma for Up To $1.5 Billion

PTC Therapeutics, Inc. announced an agreement with Royalty Pharma plc. to monetize up to $1.5 billion of the Evrysdi royalty stream.

October 19, 2023
·
6 min read
BioForest

Altoida to Present Poster Presentations Highlighting Augmented Reality-Based Cognitive Assessment at CTAD 2023

Altoida announced today it will be presenting poster presentations at the 16th Annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, held in Boston and online, October 24-27, 2023.

October 19, 2023
·
2 min read
Genetown

Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting

Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting.

October 19, 2023
·
8 min read
BioMidwest

MAIA Biotechnology to Present Preliminary Safety and Efficacy Data from THIO-101 Phase 2 Clinical Trial at European Society for Medical Oncology Congress 2023

MAIA Biotechnology, Inc. today announced that preliminary safety and efficacy data from its ongoing Phase 2 clinical trial, THIO-101, was accepted for poster presentation at the European Society for Medical Oncology (ESMO) Congress 2023, being held in Madrid, Spain, October 20-24, 2023.

October 19, 2023
·
6 min read
Business

Model N Announces Date of Fourth Quarter and Fiscal Year 2023 Financial Results

Model N, Inc., the leader in revenue optimization and compliance, plans to announce financial results for the fourth quarter and fiscal year 2023 after market close on Thursday, November 9, 2023.

October 19, 2023
·
1 min read
Deals

Thomas Scientific Broadens Portfolio and Sales Expertise With the Acquisition of Arrowhead Forensics

North America’s largest pure-play distributor of scientific products, Thomas Scientific, has completed the acquisition of Lenexa, KS based forensics product provider Arrowhead Forensics.

October 19, 2023
·
3 min read
Business

Qnovia Enters Collaboration with University of Virginia to Advance Inhaled Drug Candidates for Treating Infectious Diseases

Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, today announced it has entered into a drug development collaboration with the University of Virginia (UVA) to advance novel inhaled-drug candidates for treating bacterial infections in the lungs.

October 19, 2023
·
3 min read
Drug Development

Amylyx Pharmaceuticals to Present Clinical Trial Design of ORION, a Phase 3 Global Study of AMX0035 in Progressive Supranuclear Palsy (PSP), at the Neuro2023 PSP and CBD International Research Symposium

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced an upcoming presentation at Neuro2023 on the design of ORION, a planned global, Phase 3 clinical trial of AMX0035 (sodium phenylbutyrate and taurursodiol [PB&TURSO]) in progressive supranuclear palsy (PSP).

October 19, 2023
·
8 min read
Drug Development

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Marburg Vaccine in Uganda

The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus.

October 19, 2023
·
6 min read
MustGrow Announces Participation at Biocontrol Industry Conference and Investor Webinar

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) will be participating in next week’s Annual Biocontrol Industry Meeting

October 19, 2023
·
4 min read